The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use
Abstract
IMPORTANCE: Prescription Drug Monitoring Program (PDMP) and pill mill laws are among the principal means states use to reduce prescription drug abuse and diversion, yet little high-quality evidence exists regarding their effect. OBJECTIVE: To quantify the effect of Florida's PDMP and pill mill laws on overall and high-risk opioid prescribing and use. DESIGN, SETTING, AND PARTICIPANTS: We applied comparative interrupted time-series analyses to IMS Health LifeLink LRx data to characterize the effect of PDMP and pill mill law implementation on a closed cohort of prescribers, retail pharmacies, and patients from July 2010 through September 2012 in Florida (intervention state) compared with Georgia (control state). We conducted sensitivity analyses, including varying length of observation and modifying requirements for continuous observation of individuals throughout the study period. MAIN OUTCOMES AND MEASURES: Total opioid volume, mean morphine milligram equivalent (MME) per transaction, mean days' supply per transaction, and total number of opioid prescriptions dispensed. Analyses were conducted per prescriber and per patient, in aggregate and after stratifying by volume of baseline opioid prescribing for prescribers and use for patients. RESULTS: From July 2010 through September 2012, a cohort of 2.6 million patients, 431,890 prescribers, and 2829 pharmacies was associated with approximately 480 million prescriptions in Florida and Georgia, 7.7% of which were for opioids. Total monthly opioid volume, MME per transaction, days' supply, and prescriptions dispensed were higher in Florida than Georgia before implementation. Florida's laws were associated with statistically significant declines in opioid volume (2.5 kg/mo, P<.05; equivalent to approximately 500,000 5-mg tablets of hydrocodone bitartrate per month) and MME per transaction (0.45 mg/mo, P<.05), without any change in days' supply. Twelve months after implementation, the policies were associated with approximately a 1.4% decrease in opioid prescriptions, 2.5% decrease in opioid volume, and 5.6% decrease in MME per transaction. Reductions were limited to prescribers and patients with the highest baseline opioid prescribing and use. Sensitivity analyses, varying time windows, and enrollment criteria supported the main results. CONCLUSIONS AND RELEVANCE: Florida's PDMP and pill mill laws were associated with modest decreases in opioid prescribing and use. Decreases were greatest among prescribers and patients with the highest baseline opioid prescribing and use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Self-citationOpioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
Trends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,137
Characteristics of Opioid Prescriptions in 2009
Volkow, N. D. (2011) · JAMA · doi:10.1001/jama.2011.401 · Cited by 815
Drug poisoning deaths in the United States, 1980-2008.
Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Miniño, A. (2011) · PubMed · Cited by 399
Ziegel, E. R., Diggle, P., Liang, K., & Zeger, S. (1995) · Technometrics · doi:10.2307/1269941 · Cited by 321
Mandatory Use of Prescription Drug Monitoring Programs
Haffajee, R. L., Jena, A. B., & Weiner, S. G. (2015) · JAMA · doi:10.1001/jama.2014.18514 · Cited by 212
Congressional Research Service
(2014) · Congress A to Z · doi:10.4135/9781452287508.n93 · Cited by 177
Decline in drug overdose deaths after state policy changes - Florida, 2010-2012.
Johnson, H., Paulozzi, L. J., Porucznik, C. A., Mack, K. A., & Herter, B. (2014) · PubMed Central · Cited by 165
Prescription Drug Monitoring and Dispensing of Prescription Opioids
Brady, J. E., Wunsch, H., DiMaggio, C., Lang, B. H., Giglio, J., & Li, G. (2014) · Public Health Reports® · doi:10.1177/003335491412900207 · Cited by 164
Association between non-medical and prescriptive usage of opioids
Dasgupta, N., Kramer, E. D., Zalman, M.-A., Carino, S., Smith, M. Y., Haddox, J. D., & Wright, C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.08.019 · Cited by 131
Delcher, C., Wagenaar, A. C., Goldberger, B. A., Cook, R. L., & Maldonado‐Molina, M. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.010 · Cited by 126
Reductions in prescription opioid diversion following recent legislative interventions in Florida
Surratt, H. L., O’Grady, C. L., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., & Chen, M. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3553 · Cited by 113
Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009) · Substance Abuse Research and Treatment · doi:10.4137/sart.s2345 · Cited by 97
Rethinking Opioid Prescribing to Protect Patient Safety and Public Health
Alexander, G. C., Kruszewski, S. P., & Webster, D. W. (2012) · JAMA · doi:10.1001/jama.2012.14282 · Cited by 92
Self-citationObserved transition from opioid analgesic deaths toward heroin
Dasgupta, N., Creppage, K. E., Austin, A. E., Ringwalt, C. L., Sanford, C., & Proescholdbell, S. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.005 · Cited by 63
Drug overdose deaths--Florida, 2003-2009.
(2011) · Cited by 38
Hwang, C. S., Turner, L. W., Kruszewski, S. P., Kolodny, A., & Alexander, G. C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6520 · Cited by 30
Self-citation
Cited by
Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review
Bicket, M. C., Long, J. J., Pronovost, P. J., Alexander, G. C., & Wu, C. L. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0831 · Cited by 873
Self-citationGlobal patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 299
Today’s fentanyl crisis: Prohibition’s Iron Law, revisited
Beletsky, L., & Davis, C. S. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.050 · Cited by 283
Metadata
- Authors
- Rutkow, L., Chang, H.-Y., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. C.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2015-10-01
- Volume
- 175
- Issue
- 10
- Pages
- 1642
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W1871811247
- Cited by
- 262
- References
- 19
- FWCI
- 30.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.